IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,555,177 | -22.1% | 161,493 | -6.7% | 0.00% | -33.3% |
| Q2 2023 | $1,995,359 | +32.2% | 173,058 | +32.2% | 0.00% | +50.0% |
| Q1 2023 | $1,509,346 | -9.9% | 130,906 | -3.2% | 0.00% | -33.3% |
| Q4 2022 | $1,675,078 | +6.7% | 135,196 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $1,570,000 | -16.4% | 136,207 | -12.9% | 0.00% | 0.0% |
| Q2 2022 | $1,877,000 | +317.1% | 156,402 | +336.5% | 0.00% | +200.0% |
| Q1 2022 | $450,000 | -92.8% | 35,827 | -93.3% | 0.00% | -87.5% |
| Q4 2021 | $6,214,000 | -44.8% | 532,929 | -38.1% | 0.01% | -50.0% |
| Q3 2021 | $11,253,000 | +29.5% | 861,639 | +27.6% | 0.02% | +33.3% |
| Q2 2021 | $8,689,000 | +4951.7% | 675,170 | +4295.6% | 0.01% | – |
| Q1 2021 | $172,000 | +8.2% | 15,360 | +10.5% | 0.00% | – |
| Q4 2020 | $159,000 | -20.5% | 13,902 | -37.5% | 0.00% | – |
| Q3 2020 | $200,000 | +41.8% | 22,232 | +62.4% | 0.00% | – |
| Q2 2020 | $141,000 | +9.3% | 13,692 | +7.5% | 0.00% | – |
| Q1 2020 | $129,000 | -21.3% | 12,736 | +3.2% | 0.00% | – |
| Q4 2019 | $164,000 | +34.4% | 12,344 | -13.1% | 0.00% | – |
| Q3 2019 | $122,000 | -21.3% | 14,204 | +0.6% | 0.00% | – |
| Q2 2019 | $155,000 | -10.9% | 14,124 | +9.6% | 0.00% | – |
| Q1 2019 | $174,000 | +19.2% | 12,884 | -8.5% | 0.00% | – |
| Q4 2018 | $146,000 | -44.1% | 14,074 | -0.5% | 0.00% | – |
| Q3 2018 | $261,000 | -8.4% | 14,144 | -5.0% | 0.00% | – |
| Q2 2018 | $285,000 | +28.4% | 14,884 | +3.5% | 0.00% | – |
| Q1 2018 | $222,000 | +3.3% | 14,374 | 0.0% | 0.00% | – |
| Q4 2017 | $215,000 | -6.5% | 14,374 | -1.3% | 0.00% | – |
| Q3 2017 | $230,000 | -15.8% | 14,564 | +0.9% | 0.00% | – |
| Q2 2017 | $273,000 | -57.1% | 14,434 | -61.3% | 0.00% | -100.0% |
| Q1 2017 | $636,000 | -40.2% | 37,264 | -46.4% | 0.00% | -50.0% |
| Q4 2016 | $1,063,000 | +399.1% | 69,504 | +418.5% | 0.00% | – |
| Q3 2016 | $213,000 | +29.1% | 13,404 | +6.3% | 0.00% | – |
| Q2 2016 | $165,000 | +34.1% | 12,614 | +12.5% | 0.00% | – |
| Q1 2016 | $123,000 | -6.8% | 11,214 | -1.8% | 0.00% | – |
| Q4 2015 | $132,000 | +11.9% | 11,414 | +0.9% | 0.00% | – |
| Q3 2015 | $118,000 | -13.2% | 11,314 | 0.0% | 0.00% | – |
| Q2 2015 | $136,000 | -23.6% | 11,314 | +1.8% | 0.00% | – |
| Q1 2015 | $178,000 | +3.5% | 11,114 | -0.9% | 0.00% | – |
| Q4 2014 | $172,000 | +18.6% | 11,214 | 0.0% | 0.00% | – |
| Q3 2014 | $145,000 | -57.0% | 11,214 | -49.0% | 0.00% | -100.0% |
| Q2 2014 | $337,000 | +155.3% | 22,004 | +105.4% | 0.00% | – |
| Q1 2014 | $132,000 | +13.8% | 10,714 | +7.0% | 0.00% | – |
| Q4 2013 | $116,000 | -7.2% | 10,014 | -4.8% | 0.00% | – |
| Q3 2013 | $125,000 | +21.4% | 10,514 | +1.9% | 0.00% | – |
| Q2 2013 | $103,000 | – | 10,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |